Epigenetic regulation of tissue factor inducibility in endothelial cell senescence

David J Kurz1, Sravan Payeli2, Helen Greutert2

  • 1Center for Molecular Cardiology, Institute of Physiology, University of Zurich, Switzerland; Cardiology, Triemli Hospital, Zurich, Switzerland.

Insights

Cellular senescence, a state of permanent cell-cycle exit, inhibits tissue factor (TF) gene induction in endothelial cells. This occurs via chromatin remodeling, suggesting a novel anti-cancer mechanism for senescence.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Oncology

Background:

  • Cellular senescence is a state of irreversible cell cycle arrest with implications for tumor suppression and aging.
  • Tissue Factor (TF) is crucial in hemostasis and cancer progression.
  • Senescence involves altered gene expression, but its impact on TF inducibility is unclear.

Purpose of the Study:

  • To investigate the effect of cellular senescence on tissue factor (TF) gene induction in human umbilical vein endothelial cells.
  • To elucidate the molecular mechanisms underlying changes in TF expression during senescence.
  • To explore the potential anti-cancer role of senescence-induced TF inhibition.

Main Methods:

  • Induction of cellular senescence in human umbilical vein endothelial cells.
  • Stimulation with thrombin and phorbol-12-myristate-13-acetate to assess TF induction.
  • Analysis of downstream signaling pathways and TF mRNA stability.
  • Chromatin immunoprecipitation (ChIP) to examine TF promoter chromatin structure.
  • Reversal of senescence using telomerase reverse transcriptase (TERT) transduction.

Main Results:

  • Senescent endothelial cells exhibited a significant loss of TF gene inducibility.
  • This loss was not due to altered signaling or mRNA degradation.
  • ChIP analysis revealed chromatin remodeling and histone H3 hypoacetylation at the TF promoter in senescent cells.
  • TERT transduction reversed senescence and restored TF inducibility.

Conclusions:

  • Cellular senescence silences TF gene expression through epigenetic modifications (chromatin remodeling and histone hypoacetylation).
  • This epigenetic silencing of TF is a novel mechanism contributing to the tumor-suppressive function of senescence.
  • Senescence-induced inhibition of TF offers a potential anti-cancer strategy by limiting pro-tumorigenic pathways.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
2.7K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
70.5K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.4K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
5.9K
Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.4K